The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.
about
The rab11 effector protein FIP1 regulates adiponectin trafficking and secretionUp- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implicationPleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future PerspectivesCurrent Management of NAFLDPPARs: Protectors or Opponents of Myocardial Function?Inflammation, oxidative stress and renin angiotensin system in atherosclerosisAdvancing Biological Understanding and Therapeutics Discovery with Small-Molecule ProbesInterventions to preserve beta-cell function in the management and prevention of type 2 diabetesThe role of adipokines in chronic inflammationHypoadiponectinaemia in diabetes mellitus type 2: molecular mechanisms and clinical significanceNonalcoholic fatty liver disease: new treatmentsMolecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functionsA family of Acrp30/adiponectin structural and functional paralogsMechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitizationAdiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeInsulin resistance in chronic kidney disease: a systematic review.The current role of thiazolidinediones in diabetes management.Inhibition of 11betaHSD1 with the S-phenylethylaminothiazolone BVT116429 increases adiponectin concentrations and improves glucose homeostasis in diabetic KKAy miceFat in liver/muscle correlates more strongly with insulin sensitivity in rats than abdominal fat.Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study.The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin.Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation.Role of thiazolidinediones, insulin sensitizers, in non-alcoholic fatty liver diseaseAdipocytokine and ghrelin levels in relation to cardiovascular disease risk factors in women at midlife: longitudinal associationsSepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patientsMolecular Characterization of the Tumor Suppressor Candidate 5 Gene: Regulation by PPARgamma and Identification of TUSC5 Coding Variants in Lean and Obese Humans.A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survivalProteasomal degradation of retinoid X receptor alpha reprograms transcriptional activity of PPARgamma in obese mice and humansDistinct vascular and metabolic effects of different classes of anti-hypertensive drugs.Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemiaPPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression.Serum total adiponectin is associated with impaired glucose tolerance in Asian Indian females but not in males.High-molecular-weight adiponectin and incident ischemic stroke in postmenopausal women: a Women's Health Initiative Study.Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women.High-fat and obesogenic diets: current and future strategies to fight obesity and diabetes.The role of adiponectin in cancer: a review of current evidence.Phosphorylation of extracellular signal-regulated kinase (ERK)-1/2 Is associated with the downregulation of peroxisome proliferator-activated receptor (PPAR)-γ during polymicrobial sepsis.AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome.Dohaekseunggi-tang extract inhibits obesity, hyperlipidemia, and hypertension in high-fat diet-induced obese mice.
P2860
Q21132508-9D6E1DC1-EF69-434B-B0EC-18B7B741F65FQ24633408-5E566565-68D3-4EB8-88BD-1B7021033441Q26747009-4C531038-E3C0-49D4-85B7-489D373EBB06Q26752729-19B186E5-8D5E-4BCE-A6F4-297F2FFEBDD2Q26771753-88A0F344-BF25-48B9-8673-42E8C93DD6D3Q26795756-BD738FA6-E6A0-496D-B632-540AF586036DQ26829985-B664916E-DCD8-41F2-91D0-2981E039E7D6Q26830871-BACDCE3D-1DB7-4B6B-AFF5-4AA115F192B7Q26852901-AE7B7EEB-FE97-4BF0-B3FE-854C87C062FFQ26865140-1ED5326F-FF72-4372-8A1A-63FB667DA868Q27021161-B11BF77A-5EFC-469E-8035-AAD16BE37708Q28508387-2CC9C243-1F4B-421B-AFF3-1F7D0D773BAEQ28513966-FCD6651E-A1E3-4C50-9533-65147FC5E347Q29028203-CEFAC8CE-9AEB-4B08-BCF0-D52B47E5BB49Q29619211-0C0B1428-57F5-479F-AEA9-7052BEDC4B6DQ30244271-86108212-6C89-41DF-8F94-B6CD9DF35429Q30250347-847E4442-BFF6-4F0A-9C84-BAF61D4DEA24Q33319513-34D54524-B5AA-4253-88CA-F53FD4C94F81Q33379065-257BB60B-5D6E-4C58-A96A-4BB4DC3A58C7Q33509887-581AC260-75F1-4823-8A11-33A3FBD7BDC3Q33572275-3463C4D8-0E7B-4C5F-8E82-A8672FD756DBQ33604584-E0EC3697-F06B-42B4-A843-B700F1976729Q33607697-54609DD1-5992-4F8E-BC77-0809CE863053Q33648509-65375760-EB08-4683-8878-6ADAA1E210D9Q33687854-E8D9B95F-6FDD-4453-9CFD-32F047D55BCEQ33696469-A486848E-D748-448C-A7F6-5A116E207114Q33806363-693888C8-9C04-4DE3-8C53-1715CC1B73D6Q33815655-86A65378-D234-4288-A9CD-D8547FF2E020Q33821236-D796EE56-A610-48DF-9E9A-90286C7F256AQ33868771-D5FC702F-F307-4C8A-B838-20363D0E0523Q33884464-04143C22-618A-4A55-9BA5-EEEB00C9544EQ33960389-07743F86-5C3D-466A-9AAF-C3B0C07FBD46Q33979722-0D740331-F572-49CC-B86F-45E0623EE2B1Q34007667-F51FE59C-A6F3-4E08-8D4E-9E86827884E3Q34024266-A2060A33-C00A-419E-B09C-9BB428AE315BQ34212924-F605506E-2F36-491A-9997-F3E01D8AF106Q34271986-F8DA0B69-31C6-4BB8-AC37-3D3F4FBB77FBQ34274262-D40A2D51-EE72-40BF-90C8-3B21CC367A6DQ34310675-A59D5EDB-9FA5-4AFA-91E1-23B997A18AD4Q34320386-54270FC4-E272-4D00-8A0A-976EEA6F3B1B
P2860
The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
The effect of thiazolidinedion ...... and type 2 diabetic subjects.
@en
The effect of thiazolidinedion ...... and type 2 diabetic subjects.
@nl
type
label
The effect of thiazolidinedion ...... and type 2 diabetic subjects.
@en
The effect of thiazolidinedion ...... and type 2 diabetic subjects.
@nl
prefLabel
The effect of thiazolidinedion ...... and type 2 diabetic subjects.
@en
The effect of thiazolidinedion ...... and type 2 diabetic subjects.
@nl
P2093
P1433
P1476
The effect of thiazolidinedion ...... and type 2 diabetic subjects.
@en
P2093
Andrea L Hevener
Joseph G Yu
Madhur Sinha
Rodney A Norman
Sandrine Javorschi
Yolanta T Kruszynska
P304
P356
10.2337/DIABETES.51.10.2968
P407
P577
2002-10-01T00:00:00Z